M. Baptist

Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.

H. Lane, M. Šuša, T. O'reilly, 2004, Bone.

μ-Opioid Receptors: Correlation of Agonist Efficacy for Signalling with Ability to Activate Internalization

S. Charlton, C. Krasel, W. Dewey, 2010, Molecular Pharmacology.

Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease.

D. Ovcharenko, E. Rubin, G. Loots, 2005, Genome research.

signalling with ability to activate internalization

S. Charlton, C. Krasel, W. Dewey, 2010 .